Artificial intelligence-enabled discovery of a RIPK3 inhibitor with neuroprotective effects in an acute glaucoma mouse model
Abstract. Background:. Retinal ganglion cell (RGC) death caused by acute ocular hypertension is an important characteristic of acute glaucoma. Receptor-interacting protein kinase 3 (RIPK3) that mediates necroptosis is a potential therapeutic target for RGC death. However, the current understanding...
Saved in:
Main Authors: | Xing Tu, Zixing Zou, Jiahui Li, Simiao Zeng, Zhengchao Luo, Gen Li, Yuanxu Gao, Kang Zhang, Jing Ni |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2025-01-01
|
Series: | Chinese Medical Journal |
Online Access: | http://journals.lww.com/10.1097/CM9.0000000000003387 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
RIPK1 expression and inhibition in tauopathies: implications for neuroinflammation and neuroprotection
by: Ignacio Silva-Llanes, et al.
Published: (2025-01-01) -
RIPK1 in necroptosis and recent progress in related pharmaceutics
by: Kunhou Yao, et al.
Published: (2025-02-01) -
Innovative IOP-Independent Neuroprotection and Neuroregeneration Strategies in the Pipeline for Glaucoma
by: James C. Tsai
Published: (2020-01-01) -
A microscale thermophoresis-based enzymatic RNA methyltransferase assay enables the discovery of DNMT2 inhibitors
by: Zarina Nidoieva, et al.
Published: (2025-02-01) -
Role of hepatocyte RIPK1 in maintaining liver homeostasis during metabolic challenges
by: Weigao Zhang, et al.
Published: (2025-01-01)